Kiritsy Christopher Pinsider trades
In SEC Form 4 filings, Kiritsy Christopher P is listed as Director of Palvella Therapeutics, Inc. (PVLA). In the last 90 days, Kiritsy Christopher P sold $49.1K of Palvella Therapeutics, Inc. (PVLA) on the open market and bought none.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| PVLAPalvella Therapeutics, Inc. | Director | 3 | Sep 4 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-04
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| PVLAPalvella Therapeutics, Inc. | Sep 2 | Sep 4 | M | 313 | $127.20 | $39,814 | 563 | No | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Sep 2 | Sep 4 | S | 313 | $157.00 | Sale −$49,141 | 250 | No | Form 4 |
| PVLAPalvella Therapeutics, Inc. | Sep 2 | Sep 4 | M · derivative | 313 | $127.20 | $39,814 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.